• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Greenhalgh J, Bagust A, Boland A, et al. Clopidogrel and Modified-Release Dipyridamole for the Prevention of Occlusive Vascular Events (Review of Technology Appraisal No. 90): A Systematic Review and Economic Analysis. Southampton (UK): NIHR Evaluation, Trials and Studies Coordinating Centre (UK); 2011 Sep. (Health Technology Assessment, No. 15.31.)

List of abbreviations

ACS

acute coronary syndrome

ASA

acetylsalicylic acid (i.e. aspirin)

ATTC

Antithrombotic Trialist's Collaboration

BHF

British Heart Foundation

BNF

British National Formulary

CAD

coronary artery disease

CAPRIE

Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events

CEAC

cost-effectiveness acceptability curve

CHD

coronary heart disease

CHF

congestive heart failure

CI

confidence interval

CLOP

clopidogrel

CVD

cardiovascular disease

DHDS

Diabetes, Heart Disease and Stroke prevention project

ECG

electrocardiogram

ESPRIT

European/Australasian Stroke Prevention in Reversible Ischaemia Trial

ESPS-2

Second European Stroke Prevention Study

GP

general practitioner

HR

hazard ratio

HRQoL

health-related quality of life

ICER

incremental cost-effectiveness ratio

IS

ischaemic stroke

ITT

intention to treat

LYG

life-year gained

LYS

life-year saved

MHRA

Medicines and Healthcare products Regulatory Agency

MI

myocardial infarction

MIMS

Monthly Index of Medical Specialities

MPES

Multi-parameter Evidence Synthesis Research Group

MRD

modified-release dipyridamole

MS

manufacturer's submission

MTA

multiple technology assessment

MTC

mixed-treatment comparison

MVD

multivascular disease

NICE

National Institute for Health and Clinical Excellence

NSF

National Service Framework

NSTEMI

non-ST-segment elevation myocardial infarction

OR

odds ratio

OVE

occlusive vascular event

PAD

peripheral arterial disease

PPI

proton pump inhibitor

PRoFESS

Prevention Regimen For Effectively avoiding Second Strokes

PSA

probabilistic sensitivity analysis

PSSRU

Personal Social Services Research Unit

QALY

quality-adjusted life-year

QoL

quality of life

RCT

randomised controlled trial

RRR

relative risk reduction

RR

relative risk

SR

systematic review

STEMI

ST-segment elevation myocardial infarction

TA

technology appraisal

TIA

transient ischaemic attack

WTP

willingness to pay

All abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices, in which case the abbreviation is defined in the figure legend or in the notes at the end of the table.

© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

Cover of Clopidogrel and Modified-Release Dipyridamole for the Prevention of Occlusive Vascular Events (Review of Technology Appraisal No. 90): A Systematic Review and Economic Analysis
Clopidogrel and Modified-Release Dipyridamole for the Prevention of Occlusive Vascular Events (Review of Technology Appraisal No. 90): A Systematic Review and Economic Analysis.
Health Technology Assessment, No. 15.31.
Greenhalgh J, Bagust A, Boland A, et al.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...